Replies to post #366499 on Innovation Pharmaceuticals Inc (IPIX)

[farrell90]

The in vitro studies suggest Brilacidin is effective at a low dose and cell toxicity occurs at a relatively high dose, thus the excellent Selectivity Index of 426.

We will have a better idea about future dosing when the Phase 2 study reports.

GLTA, Farrell